# Intermittent Hypoxia and Caffeine in Infants Born Preterm

> **NCT03321734** · PHASE2 · COMPLETED · sponsor: **Children's National Research Institute** · enrollment: 170 (actual)

## Conditions studied

- Intermittent Hypoxia

## Interventions

- **DRUG:** Caffeine
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03321734
- **Lead sponsor:** Children's National Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-18
- **Primary completion:** 2023-06-01
- **Final completion:** 2023-06-01
- **Target enrollment:** 170 (ACTUAL)
- **Last updated:** 2023-09-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03321734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03321734, "Intermittent Hypoxia and Caffeine in Infants Born Preterm". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03321734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*